NCT06084572 Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
| NCT ID | NCT06084572 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitair Ziekenhuis Brussel |
| Condition | GERD |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-09-29 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2023-09-29 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Commonly, in clinical practice an automated analysis of pH-MII tracings is obtained.
Eligibility Criteria
Inclusion Criteria: * Adult patients aged 18 - 80 years old; * pH-MII performed off PPI Exclusion Criteria: * Prior upper GI endoscopy indicative of structural disease (except for oesophagitis or hiatal hernia). * Incomplete pH-MII (less than 21 hours recording); * Ph-MII performed on PPI * Suboptimal quality of the tracings preventing interpretation in clinical practice; * Prior oesophageal (including anti-reflux intervention) or gastric surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06084572 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying GERD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06084572 currently recruiting?
Yes, NCT06084572 is actively recruiting participants. Contact the research team at sebastien.kindt@uzbrussel.be for enrollment information.
Where is the NCT06084572 trial being conducted?
This trial is being conducted at Anderlecht, Belgium, Jette, Belgium, München, Germany.
Who is sponsoring the NCT06084572 clinical trial?
NCT06084572 is sponsored by Universitair Ziekenhuis Brussel. The trial plans to enroll 120 participants.